SLU-PP-332 is a promising research compound often described as an exercise mimetic because it activates estrogen-related receptors and may help drive metabolic changes similar to endurance exercise. It has attracted attention in obesity, mitochondrial health, and energy expenditure research, but it is still a preclinical compound and not approved for human use.
SLU-PP-332 is a synthetic small molecule developed to activate estrogen-related receptors, especially ERRα, and in some references ERRβ and ERRγ as well. These receptors are important regulators of mitochondrial function, fatty acid oxidation, and cellular energy metabolism.
How SLU-PP-332 Works
SLU-PP-332 appears to activate gene programs associated with aerobic exercise. This can increase energy expenditure, enhance fat oxidation, and support mitochondrial biogenesis, which is why it is often called an exercise mimetic.
Research summaries suggest it may improve oxidative metabolism in skeletal muscle and other tissues without necessarily affecting appetite or food intake. That makes it different from many weight-loss approaches that focus primarily on appetite suppression.
Research Findings
Preclinical studies reported that SLU-PP-332 can increase mitochondrial respiration and trigger exercise-like metabolic adaptations. In mouse models, it has also been linked to reduced body weight, lower fat mass, improved lipid markers, and better glucose handling.
SLU-PP-332 is a preclinical exercise mimetic that activates ERR receptors to support energy expenditure, fat oxidation, and mitochondrial function. Learn how SLU-PP-332 works, its research benefits, and why it is gaining attention in metabolic health studies.
Reviews
There are no reviews yet.